中药新药与临床药理
中藥新藥與臨床藥理
중약신약여림상약리
TRADITIONAL CHINESE DRUG RESEARCH&CLINICAL PHARMACOLOGY
2001年
1期
3-6
,共4页
@羚黄散/治疗应用%@急性非特异性下尿路感染/中药疗法
@羚黃散/治療應用%@急性非特異性下尿路感染/中藥療法
@령황산/치료응용%@급성비특이성하뇨로감염/중약요법
@Linghuang powder /therapy use%acu te nonspecific lower urinary tract infect ion /TCD therapy
目的：评价羚黄散治疗急性非特异性下尿路感染下焦湿热证 的疗效和安全性。方法：采用随机对照方法，将 414 例患者分为治疗组、对照组和开放治 疗组，以观察羚黄散对急性非特异性下尿路感染的临床疗效及安全性。结果：羚黄散治疗组 临床近期疗效的愈显率为 71.78%，总有效率为 92.02%；尿常规治疗后总改善率为 95.21%，尿细菌学治疗后总改善率为 79.37%。羚黄散治疗组优于对照组（P<0 .01）。
目的：評價羚黃散治療急性非特異性下尿路感染下焦濕熱證 的療效和安全性。方法：採用隨機對照方法，將 414 例患者分為治療組、對照組和開放治 療組，以觀察羚黃散對急性非特異性下尿路感染的臨床療效及安全性。結果：羚黃散治療組 臨床近期療效的愈顯率為 71.78%，總有效率為 92.02%；尿常規治療後總改善率為 95.21%，尿細菌學治療後總改善率為 79.37%。羚黃散治療組優于對照組（P<0 .01）。
목적：평개령황산치료급성비특이성하뇨로감염하초습열증 적료효화안전성。방법：채용수궤대조방법，장 414 례환자분위치료조、대조조화개방치 료조，이관찰령황산대급성비특이성하뇨로감염적림상료효급안전성。결과：령황산치료조 림상근기료효적유현솔위 71.78%，총유효솔위 92.02%；뇨상규치료후총개선솔위 95.21%，뇨세균학치료후총개선솔위 79.37%。령황산치료조우우대조조（P<0 .01）。
Objective: To assess the effect of Linghuang powder ( LHP) in treating acute nonspecific lower urinary tract infection (ANLUTI) with l ower-Jiao damp-heat syndrome and evaluate its safety. Methods: A randomized cont rolled design was adopted. Four hundred and fourteen patients were allocated to LHP treatment group, control group and open treatment group. Results: The marked ly effective rate of short-term treatment with LHP was 71.78%, and the total effective rate was 92.02%, the total rates of im proving urine routine and urine bacterium were 95.21% and 79.37% respectively in LHP treatment group. Conclusion:The effect of LHP for ANLUTI with lower-jiao damp-heat syndrome is better than that in the control group (P<0.01).
